EVIDENCE FOR A RESTRICTED IDIOTYPIC AND EPITOPIC SPECIFICITY OF ANTITHYROGLOBULIN AUTOANTIBODIES IN PATIENTS WITH AUTOIMMUNE-THYROIDITIS

被引:33
作者
DIETRICH, G
PIECHACZYK, M
PAU, B
KAZATCHKINE, MD
机构
[1] HOP BROUSSAIS,UNITE IMMUNOPATHOL,96 RUE DIDOT,F-75674 PARIS 14,FRANCE
[2] HOP BROUSSAIS,INSERM,U28,F-75674 PARIS 14,FRANCE
[3] UNIV MONTPELLIER 1,FAC PHARM,IMMUNOL LAB,F-34060 MONTPELLIER,FRANCE
关键词
D O I
10.1002/eji.1830210340
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Anti-thyroglobulin (TG) autoantibodies from patients with autoimmune thyroiditis express a cross-reactive alpha idiotype (Id) termed T44 which is not expressed by IgG from normal individuals. The present study demonstrates that the expression of the T44 Id is strongly associated with the recognition by anti-TG autoantibodies of a specific epitopic cluster on human TG. The epitopic reactivity of anti-TG autoantibodies was determined using a competitive inhibition assay with a panel of 15 monoclonal antibodies that define six antigenic clusters on TG. All T44+ autoantibodies from patients recognized cluster II, whereas no anti-TG IgG from healthy individuals reacted with this region. Affinity columns of Sepharose-bound intravenous therapeutic immunoglobulins which contain anti-T44 activity, retained both T44 Id-expressing antibodies and a subset of region II-specific anti-TG autoantibodies from patients with Hashimoto's disease. Restricted idiotypic and epitopic specificity may demarcate disease-associated from natural anti-TG autoantibodies, suggesting that qualitative rather than quantitative criteria should be used to identify pathological autoantibodies.
引用
收藏
页码:811 / 814
页数:4
相关论文
共 15 条
  • [1] BOUANANI M, 1989, J IMMUNOL, V143, P1129
  • [2] BRESLER SH, 1990, CLIN IMMUNOL IMMUNOP, V54, P76
  • [3] NORMAL IMMUNOGLOBULIN-G (IGG) FOR THERAPEUTIC USE (INTRAVENOUS IG) CONTAIN ANTIIDIOTYPIC SPECIFICITIES AGAINST AN IMMUNODOMINANT, DISEASE-ASSOCIATED, CROSS-REACTIVE IDIOTYPE OF HUMAN ANTI THYROGLOBULIN AUTOANTIBODIES
    DIETRICH, G
    KAZATCHKINE, MD
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 1990, 85 (03) : 620 - 625
  • [4] A MONOCLONAL ANTIIDIOTYPIC ANTIBODY AGAINST THE ANTIGEN-COMBINING SITE OF ANTI-FACTOR-VIII AUTOANTIBODIES DEFINES AN IDIOTOPE THAT IS RECOGNIZED BY NORMAL HUMAN POLYSPECIFIC IMMUNOGLOBULINS FOR THERAPEUTIC USE (IVIG)
    DIETRICH, G
    PEREIRA, P
    ALGIMAN, M
    SULTAN, Y
    KAZATCHKINE, MD
    [J]. JOURNAL OF AUTOIMMUNITY, 1990, 3 (05) : 547 - 557
  • [5] PRODUCTION AND CHARACTERIZATION OF MONOCLONAL-ANTIBODIES AGAINST HUMAN THYROGLOBULIN
    PIECHACZYK, M
    CHARDES, T
    COT, MC
    PAU, B
    BASTIDE, JM
    [J]. HYBRIDOMA, 1985, 4 (04): : 361 - 367
  • [6] ANTIGENIC DOMAINS ON THE HUMAN THYROGLOBULIN MOLECULE RECOGNIZED BY AUTOANTIBODIES IN PATIENTS SERA AND BY NATURAL AUTOANTIBODIES ISOLATED FROM THE SERA OF HEALTHY-SUBJECTS
    PIECHACZYK, M
    BOUANANI, M
    SALHI, SL
    BALDET, L
    BASTIDE, M
    PAU, B
    BASTIDE, JM
    [J]. CLINICAL IMMUNOLOGY AND IMMUNOPATHOLOGY, 1987, 45 (01): : 114 - 121
  • [7] ROSSI F, 1989, J IMMUNOL, V143, P4104
  • [8] IDIOTYPIC INTERACTIONS BETWEEN NORMAL HUMAN POLYSPECIFIC IGG AND NATURAL IGM ANTIBODIES
    ROSSI, F
    GUILBERT, B
    TONNELLE, C
    TERNYNCK, T
    FUMOUX, F
    AVRAMEAS, S
    KAZATCHKINE, MD
    [J]. EUROPEAN JOURNAL OF IMMUNOLOGY, 1990, 20 (09) : 2089 - 2094
  • [9] ROSSI F, 1990, IN PRESS CLIN EXP IM
  • [10] ROSSI F, 1989, IMMUNOL REV, V110, P315